Trametinib Placebo clinical trials

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer

This study is testing if two drugs, dabrafenib and trametinib, can help people with a specific type of thyroid cancer (DTC) that has a BRAF V600E gene change, has stopped responding to radioactive iodine, and has progressed after other treatments.